Londian Wason Targets NYSE Listing to Fund Global Expansion

The company has not yet disclosed the volume of shares or the anticipated price range for the offering. Underwriters have been granted a 30-day option to purchase additional shares to address potential over-allotments. Prospective investors should note that the firm operates under a complex structure involving Chinese subsidiaries, which carries specific legal and regulatory risks. Under U.S. securities law, the company is classified as an emerging growth company and a foreign private issuer.

Financial performance has shown a positive trajectory as the firm pivots toward public markets. Londian Wason reported a net income of 20.3 million renminbi, approximately $2.9 million, for 2025, marking a recovery from a net loss in 2024. This growth was supported by rising annual revenue, which reached 10.94 billion renminbi. Proceeds from the offering are earmarked for upgrading manufacturing processes and diversifying the company’s global product portfolio.